Long COVID

The medical world has to overcome the perception that children are not susceptible to long COVID, physicians said during a U.S. News and World Report webinar on the topic.

The antiviral nirmatrelvir, which is part of Paxlovid, was linked to a significant reduction in the risk for long COVID and post-acute death in patients with at least one risk factor for severe illness, according to researchers.

Mindfulness exercises can improve outcomes among patients with inflammatory diseases, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.

SCOTTSDALE, Ariz. — Mind-body therapy may play a key role in achieving more positive outcomes for patients with long COVID, according to a speaker at the Basic and Clinical Immunology for the Busy Clinician symposium.

Though evidence for long COVID treatments is lacking, patients have been voicing a need for more understanding and better communication about their situation, according to an expert.

SCOTTSDALE, Ariz. — In the absence of approved long COVID therapies, rheumatologists are encouraged to treat the symptoms and “listen empathically,” noted a presenter at the Basic and Clinical Immunology for the Busy Clinician symposium.

Black and Hispanic individuals were more likely to experience long COVID-related symptoms and health problems compared with white individuals, according to a new study.

A recent report found that about 18% of people with long COVID have been unable to return to work since their diagnosis, but primary care physicians can help patients manage the condition, an expert said.

Prolonged COVID-19 symptoms, including severe fatigue, were more common among patients infected during the pre-delta period compared with the later delta and omicron periods, researchers found.